{
  "trial_id": "NCT00447057",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, performance status, prior treatment history, baseline tumor size, baseline laboratory values (e.g., hemoglobin, white blood cell count, liver function tests, renal function tests), smoking status, weight, height, comorbidities.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status",
          "performance status"
        ],
        [
          "Smoking status",
          "smoking status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Basis for Diagnosis",
        "Initial Pathological Diagnosis",
        "Stage of Disease at Study Entry",
        "Pack-years",
        "smokers only"
      ],
      "remaining_candidate_features": [
        "Age",
        "prior treatment history",
        "baseline tumor size",
        "baseline laboratory values (e.g., hemoglobin, white blood cell count, liver function tests, renal function tests)",
        "weight",
        "height",
        "comorbidities"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Performance Status, Previous Treatment Regimen, Bone Marrow Reserve, Renal Function, Hepatic Function,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status",
          "Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Region of Enrollment",
        "Basis for Diagnosis",
        "Initial Pathological Diagnosis",
        "Stage of Disease at Study Entry",
        "Smoking status",
        "Pack-years",
        "smokers only"
      ],
      "remaining_candidate_features": [
        "Age",
        "Previous Treatment Regimen",
        "Bone Marrow Reserve",
        "Renal Function",
        "Hepatic Function"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Histology, Performance Status, Number of Prior Chemotherapy Regimens, Best Response to Prior Chemotherapy, Time Since Last Chemotherapy, ECOG Performance Status, Smoking History, Pack Years of Smoking.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status",
          "ECOG Performance Status"
        ],
        [
          "Smoking status",
          "Smoking History"
        ],
        [
          "Pack-years",
          "Pack Years of Smoking"
        ]
      ],
      "remaining_reference_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Basis for Diagnosis",
        "Initial Pathological Diagnosis",
        "Stage of Disease at Study Entry",
        "smokers only"
      ],
      "remaining_candidate_features": [
        "Age",
        "Histology",
        "Performance Status",
        "Number of Prior Chemotherapy Regimens",
        "Best Response to Prior Chemotherapy",
        "Time Since Last Chemotherapy"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, performance status, histological subtype of NSCLC, number of prior chemotherapy regimens, time since last chemotherapy, presence of metastases, smoking history, pack-years of smoking, body mass index (BMI), serum biomarkers (e.g. carcinoembryonic antigen (CEA), cytokeratin fragment 21-1 (CYFRA 21-1)), liver and renal function tests, complete blood count (CBC).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status",
          "performance status"
        ],
        [
          "Initial Pathological Diagnosis",
          "histological subtype of NSCLC"
        ],
        [
          "Stage of Disease at Study Entry",
          "presence of metastases"
        ],
        [
          "Smoking status",
          "smoking history"
        ],
        [
          "Pack-years",
          "pack-years of smoking"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "Basis for Diagnosis",
        "smokers only"
      ],
      "remaining_candidate_features": [
        "Age",
        "ethnicity",
        "number of prior chemotherapy regimens",
        "time since last chemotherapy",
        "body mass index (BMI)",
        "serum biomarkers (e.g. carcinoembryonic antigen (CEA), cytokeratin fragment 21-1 (CYFRA 21-1))",
        "liver and renal function tests",
        "complete blood count (CBC)"
      ]
    }
  }
}